This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Prognosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Prognosis can vary widely but appears to be most dependent on treatment (1)

  • Several randomized, controlled trials have shown that untreated autoimmune hepatitis patients have a 5-year and 10-year survival rate of 50% and 10%, respectively.
  • 60% to 80% of patients will enter remission after the proposed duration of treatment
    • approximately 50% of these patients will relapse requiring therapy resumption

Some patients require life-long immunosuppression.

Treatment failure occurs in 10% of patients that undergo treatment with prednisone.

Those who undergo liver transplantation, approximately a third of patients have a recurrence of autoimmune hepatitis.

Reference:

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.